Notice of Expiration of RFA-CA-19-042, "Informatics Technology for Cancer Research Education Resource (UE5 Clinical Trial Not Allowed)"
Notice Number:

Key Dates

Release Date:

May 6, 2020

Related Announcements

Issued by

National Cancer Institute (NCI)


The National Cancer Institute (NCI) announces the early expiration of RFA-CA-19-042 “Informatics Technology for Cancer Research Education Resource (UE5 Clinical Trial Not Allowed).

The early expiration annuls the second (and last) application due date originally announced for July 31, 2020.

RFA-CA-19-042 was intended to support a single award. The expiration of this Funding Opportunity Announcement reflects the fact that the first round of review has already allowed the NCI to select a meritorious application for funding.

The following sections of Part 1. Overview Information, Key Dates are being modified:

Currently reads

Application Due Dates(s): December 19, 2019; July 31, 2020

Modified to read

Application Due Dates(s): December 19, 2019

Currently reads

Scientific Merit Review: March-April 2020; October-November 2020

Modified to read

Scientific Merit Review: March-April 2020

Currently reads

Advisory Council Review: May 2020; January 2021

Modified to read

Advisory Council Review: May 2020

Currently reads

Earliest Start Date: July 2020; April 2021

Modified to read

Earliest Start Date: July 2020

Currently reads

Expiration Date: August 1, 2020

Modified to read

Expiration Date: May 8, 2020

All other aspects of RFA-CA-19-042 remain unchanged.


Please direct all inquiries to:

Michelle Berny-Lang, PhD
National Cancer Institute (NCI)
Telephone: 240-781-3310

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices